Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Three Month Treatment of GHRH (Growth Hormone Releasing Hormone) in the Elderly

Authors not listed

University of Pennsylvania · 2011

Abstract

The purpose of the study is to evaluate the effect of a naturally occurring hormone, called Growth Hormone Releasing Hormone (GHRH) on the muscle, bone, and fat tissues of the body. GHRH stimulates the production of growth hormone (GH), which regulates the build up of many tissues in the body, including muscles and bones. Many elderly people have low levels of GH. The overall goal of this research is to determine the efficacy of GHRH to raise levels of GH and improve these body tissues. Healthy men and women age 65 and older will receive GHRH in four doses nightly for 12 weeks and assessed for changes in muscle strength, body mass, physical performance, and how the body uses sugar.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-04 MST

Cite this

APA
Anonymous. (2011). Three Month Treatment of GHRH (Growth Hormone Releasing Hormone) in the Elderly. <em>University of Pennsylvania</em>. https://clinicaltrials.gov/study/NCT01410799
Vancouver
Anonymous. Three Month Treatment of GHRH (Growth Hormone Releasing Hormone) in the Elderly. University of Pennsylvania. 2011.
BibTeX
@misc{anon2011ThreeM, title = {Three Month Treatment of GHRH (Growth Hormone Releasing Hormone) in the Elderly}, author = {Anonymous}, journal = {University of Pennsylvania}, year = {2011}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings